The chemical class known as RNF38 Activators refers to a group of compounds that are characterized by their ability to modulate the activity of the RNF38 protein, a member of the RING (Really Interesting New Gene) finger family of E3 ubiquitin ligases. RNF38, like other proteins in its family, plays a role in the ubiquitination process, a cellular mechanism critical for regulating protein turnover. Ubiquitination involves the attachment of ubiquitin, a small regulatory protein, to specific target proteins, marking them for degradation by the proteasome or altering their cellular location and function. RNF38 Activators influence this process by enhancing the activity of RNF38, thereby potentially affecting the ubiquitination and subsequent fate of various proteins within the cell.
The mode of action of RNF38 Activators is centered on the interaction with the RNF38 protein. These compounds can bind to or interact with RNF38, leading to an increase in its E3 ligase activity. This enhancement could be due to a variety of mechanisms, such as stabilizing the protein, facilitating its interaction with E2 ubiquitin-conjugating enzymes, or promoting its binding to substrate proteins. The precise molecular mechanisms can vary depending on the specific structure and properties of each activator compound within this class. The impact of RNF38 activation is complex, as it can lead to changes in the levels and functions of numerous proteins within the cell. These proteins might be involved in a range of cellular processes, including but not limited to signal transduction, gene expression regulation, and cellular stress responses. The activation of RNF38 by these compounds represents a significant modulation of cellular biochemistry, given the central role of ubiquitination in maintaining cellular homeostasis and regulating various cellular pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can indirectly affect RNF38 by accumulating ubiquitinated proteins, potentially enhancing the demand for E3 ligase activity. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide and its derivatives modulate the ubiquitin-proteasome system, potentially affecting RNF38's activity in substrate selection or ubiquitination. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is crucial for the structural integrity of many proteins, including E3 ligases, and may indirectly influence RNF38 function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate various signaling pathways and may indirectly affect RNF38 activity through cellular stress responses. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
This compound induces oxidative stress, potentially influencing ubiquitin-proteasome system dynamics and indirectly affecting RNF38. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin, an Hsp90 inhibitor, can lead to the degradation of client proteins, potentially modifying the activity of E3 ligases like RNF38. | ||||||
MLN7243 | 1450833-55-2 | sc-507338 | 5 mg | $340.00 | ||
As an inhibitor of ubiquitin-activating enzyme E1, it indirectly affects the ubiquitination process, potentially influencing RNF38. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
By inhibiting lysosomal activity, Chloroquine can affect protein degradation pathways, potentially impacting RNF38's role in ubiquitination. | ||||||